Clinical Trial: Probiotic Intervention and Its Influence on Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Acne Vulgaris Patients

U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07277075) titled 'Probiotic Intervention and Its Influence on Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Acne Vulgaris Patients' on Nov. 29.

Brief Summary: This study aimed to assess the serum level of Leucine-rich alpha-2 glycoprotein 1 (LRG1) in Acne vulgaris (AV) individuals and evaluate the effect of probiotic therapy on these serum levels.

Study Start Date: Oct. 01, 2024

Study Type: OBSERVATIONAL

Condition: Probiotic Influence Serum Leucine-Rich Alpha-2 Glycoprotein 1 Acne Vulgaris

Intervention: DIAGNOSTIC_TEST: Serum Leucine-rich alpha-2 glycoprotein 1 (LRG1) level

Serum Leucine-rich alpha-2 glycoprotein 1 (LRG1) levels were ass...